Staff editor
George Paraskevakos, Executive Director at International Probiotics Association, discusses the future of the microbiome space.
Specific probiotic strains can improve stress-related parameters in mothers after delivery.
Iris Dothan, from Rabin Medical Center, Israel, talks about the profiling of patient with pouchitis in order to determine the benefits from microbiome manipulation.
Jean-Luc Marsat, CEO & Chairman at EverImmune, discusses the research EverImmune carries out in oncology.
Pilar Manrique Ronquillo, Research Scientist at Microviable Therapeuthics, talks about the donor-based microbiome therapeutic products research and development.
MaaT033 (capsule), which is being developed as an adjunctive and maintenance therapy to improve overall survival in allo-HSCT, has received orphan drug designation (ODD) status from the European Medicines Agency…
New Study Demonstrates Positive Effects of NORDBIOTIC Probiotic Strains on Irritable Bowel Syndrome (IBS) in Adult Patient.
Elisa Cirillo, team lead research data manager at The Hyve, talks about the importance of having high quality data and strong tools to improve the microbiome research and business.
Industry
Sponsored by
A new scientific publication on the antimicrobial, antiadhesive and co-aggregation activity against different urogenital pathogens.
Jeroen Raes, from KU Leuven, Belgium, talks about the design of clinical trials for IBD patient with microbiome based therapies.
